BioAtla Inc’s filing revealed that its Director MCBRINN SYLVIA acquired Company’s shares for reported $9320.0 on Dec 26 ’23. In the deal valued at $2.33 per share,4,000 shares were bought. As a result of this transaction, MCBRINN SYLVIA now holds 15,125 shares worth roughly $57475.0.
Then, SHORT JAY M PHD bought 50,000 shares, generating $106,910 in total proceeds. Upon buying the shares at $2.14, the Chief Executive Officer now owns 1,439,283 shares.
Before that, STEINMAN LAWRENCE bought 20,000 shares. BioAtla Inc shares valued at $41,048 were divested by the Director at a price of $2.05 per share. As a result of the transaction, STEINMAN LAWRENCE now holds 38,459 shares, worth roughly $0.15 million.
JMP Securities initiated its BioAtla Inc [BCAB] rating to a Mkt outperform in a research note published on September 15, 2022; the price target was $17. A number of analysts have revised their coverage, including Credit Suisse’s analysts, who decreased its forecast for the stock in early May from “an Outperform” to “a Neutral”. H.C. Wainwright began covering BCAB with “Buy” recommendation on March 21, 2022.
Price Performance Review of BCAB
On Friday, BioAtla Inc [NASDAQ:BCAB] saw its stock fall -3.06% to $3.80. Over the last five days, the stock has gained 10.47%. BioAtla Inc shares have risen nearly 54.47% since the year began. Nevertheless, the stocks have risen 34.28% over the past one year. While a 52-week high of $4.07 was reached on 04/04/24, a 52-week low of $1.24 was recorded on 02/01/24. SMA at 50 days reached $2.66, while 200 days put it at $2.33. A total of 1.02 million shares were traded, compared to the trading of 1.28 million shares in the previous session.
Levels Of Support And Resistance For BCAB Stock
The 24-hour chart illustrates a support level at 3.69, which if violated will result in even more drops to 3.58. On the upside, there is a resistance level at 3.95. A further resistance level may holdings at 4.10. The Relative Strength Index (RSI) on the 14-day chart is 71.19, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.77, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 12.36%. Stochastics %K at 88.84% indicates the stock is a selling.
How much short interest is there in BioAtla Inc?
A steep rise in short interest was recorded in BioAtla Inc stocks on Mar 15, 2024, growing by 90000.0 shares to a total of 5.13 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 5.04 million shares. There was a rise of 1.75%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 11.64% of the overall stock float, the days-to-cover ratio (short ratio) rose to 14.48.
The most recent change occurred on June 28, 2021 when ROTH Capital began covering the stock and recommended ‘”a Buy”‘ rating along with a $75 price target.
